{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:50:33Z","timestamp":1788483033600,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"C\u00e0tedra d\u2019Investigaci\u00f3 en Obstetr\u00edcia I Ginecologia"},{"name":"Department of Obstetrics"},{"name":"Gynaecology and Reproductive Medicine"},{"name":"Hospital Universitario Dexeus"},{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Are there any differences in the fresh (LB) and cumulative live birth rates (CLBR) of women undergoing controlled ovarian stimulation (COS) for IVF\/ICSI following pretreatment with different types of oral contraceptive pills (OCP) for different durations as compared to no-OCP?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n OCP administration for an interval of 12- to 30-day treatment period and with a 5-day washout period does not affect clinical pregnancy, LB nor cumulative LB in patients undergoing COS for an IVF cycle.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n The use of OCP is an effective way of treatment planning in IVF\/ICSI cycles, but published evidence about its effect on pregnancy and LBR is inconsistent, some studies finding decreased rates but others no difference.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n This is a retrospective analysis carried out in a University-affiliated tertiary centre between January 2009 and December 2017. Overall, 4116 infertile women between 18 and 45\u00a0years, who underwent their first ovarian stimulation cycle in our centre, were included.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n Patients were categorised into two groups as receiving OCP (n\u00a0=\u20093517) or not (no OCP, n\u00a0=\u2009599). All patients with OCP pretreatment initiated controlled ovarian stimulation (COS) 5\u00a0days post-pill. Overall, two types of OCP were used at the study\u2019s centre: ethinylestradiol (EE) 30\u00a0\u03bcg\/desogestrel 150\u00a0\u03bcg, a third-generation progesterone; or EE 30\u00a0\u03bcg\/drospirenone 3\u00a0mg, a fourth-generation progestin with mild antiandrogenic activity.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n A total of n\u00a0=\u20094116 patients were analysed, (OCP n\u00a0=\u20093517 and non-OCP n\u00a0=\u2009599). The use of OCP was independently associated with a small increase in the number of oocytes retrieved after adjusting for age, BMI, use of OCP, cause of infertility, initial dose (IU), type of gonadotropin, stimulation days, total stimulation units (total IU) (\u03b2 0.22, 95% CI 0.12\u20130.31). Cumulative LBRs were comparable between groups OCP versus non-OCP (32.4 versus 31.6%, P\u00a0=\u20090.712). Following adjustment for age, BMI, infertility diagnosis, starting and total dose, type of gonadotropin, total days of stimulation, type of insemination, number of oocytes retrieved, day of transfer and number of embryos transferred in a multiple logistic analysis, patients using OCPs had a similar probability of achieving a LB as compared with patients not-using OCPs following fresh embryo transfer (ORadj 0.89, 95% CI 0.69\u20131.15) and a similar probability for CLBR after the use of fresh and frozen embryos (ORadj 0.94, 95% CI 0.73\u20131.21). No differences were observed in ovarian stimulation and clinical outcomes between drospirenone and desogestrel OCP groups.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n Limitations are related to the retrospective nature of the study; despite the sample size, the adjustments and the multivariable regression analysis conducted, we cannot exclude the presence of confounding bias. OCP administration was not randomly assigned, not allowing to exclude the presence of selection bias. Lastly, we only used two types of OCP with durations and washout periods as per institution protocol. Therefore, we cannot exclude that longer duration of administration, a different type of OCP or different pill-free interval might have had an alternative effect on LBR or CLBR; thus, the generalizability of this study\u2019s results should be considered with caution.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Our study provides reassuring evidence that the use of 12\u201330\u00a0days OCP for cycle programming, prior to IVF, does not decrease the chance of live birth and cumulative live birth rates.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n No external funding was used for this study. This research was performed under the auspices of \u2018C\u00e0tedra d\u2019Investigaci\u00f3 en Obstetr\u00edcia I Ginecologia\u2019 of the Department of Obstetrics, Gynaecology and Reproductive Medicine, Hospital Universitario Dexeus, Universitat Aut\u00f2noma de Barcelona. The authors report no conflict of interest associated with the current study.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n NA<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/dez299","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T12:09:14Z","timestamp":1578053354000},"page":"826-836","source":"Crossref","is-referenced-by-count":22,"title":["The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF\/ICSI cycles"],"prefix":"10.1093","volume":"35","author":[{"given":"Pedro","family":"Montoya-Botero","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Dexeus University Hospital, Gran Via de Carles III, 71-75, Barcelona 08022, Spain"},{"name":"Department of Reproductive Medicine, Conceptum \u2013 Unidad de Fertilidad del Country Conceptum, Bogot\u00e1 110221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Martinez","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Dexeus University Hospital, Gran Via de Carles III, 71-75, Barcelona 08022, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rodr\u00edguez-Purata","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Dexeus University Hospital, Gran Via de Carles III, 71-75, Barcelona 08022, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Dexeus University Hospital, Gran Via de Carles III, 71-75, Barcelona 08022, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buenaventura","family":"Coroleu","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Dexeus University Hospital, Gran Via de Carles III, 71-75, Barcelona 08022, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P","family":"Polyzos","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Dexeus University Hospital, Gran Via de Carles III, 71-75, Barcelona 08022, Spain"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"2020043013460490200_ref1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. In Cochrane Gynaecology and Fertility Group, editor","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"2020043013460490200_ref2","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"On behalf of the Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women pretreated with oral contraceptives before in vitro fertilization","volume":"83","author":"Barmat","year":"2005","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.fertnstert.2006.08.098","article-title":"Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment","volume":"87","author":"Bellver","year":"2007","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/humrep\/deu065","article-title":"The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity","volume":"29","author":"Bermejo","year":"2014","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","article-title":"Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates","volume":"70","author":"Biljan","year":"1998","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.fertnstert.2012.04.024","article-title":"Can we skip weekends in GnRH antagonist cycles without compromising the final outcome?","volume":"97","author":"Bosch","year":"2012","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humrep\/del340","article-title":"Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol","volume":"22","author":"C\u00e9drin-Durnerin","year":"2007","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/humrep\/den468","article-title":"Improving the patient\u2019s experience of IVF\/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref10","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod Oxf Engl"},{"key":"2020043013460490200_ref11","volume-title":"Chapman and Hall\/CRC","author":"Faraway","year":"2016"},{"key":"2020043013460490200_ref12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006109.pub3","article-title":"Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. In Cochrane Gynaecology and Fertility Group, editor","author":"Farquhar","year":"2017","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"2020043013460490200_ref13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0015-0282(99)00631-7","article-title":"Does anovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles?","volume":"73","author":"Fukuda","year":"2000","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.fertnstert.2011.06.022","article-title":"Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial","volume":"96","author":"Garcia-Velasco","year":"2011","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rbmo.2014.09.010","article-title":"To pill or not to pill in GnRH antagonist cycles: that is the question!","volume":"30","author":"Garcia-Velasco","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"2020043013460490200_ref16","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.fertnstert.2010.04.025","article-title":"Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis","volume":"94","author":"Griesinger","year":"2010","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","article-title":"Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis","volume":"90","author":"Griesinger","year":"2008","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rbmo.2015.04.001","article-title":"To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!","volume":"31","author":"Griesinger","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"2020043013460490200_ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-11-96","article-title":"Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial","volume":"11","author":"Hauzman","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"2020043013460490200_ref20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/humrep\/del030","article-title":"Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF\/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study","volume":"21","author":"Huirne","year":"2006","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1472-6483(10)60621-9","article-title":"Effect of an oral contraceptive pill on follicular development in IVF\/ICSI patients receiving a GnRH antagonist: a randomized study","volume":"13","author":"Huirne","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2020043013460490200_ref22","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study","volume":"19","author":"Hwang","year":"2004","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5653\/cerm.2011.38.4.228","article-title":"GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF\/ICSI","volume":"38","author":"Kim","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"2020043013460490200_ref25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/dei348","article-title":"Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial","volume":"21","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejogrb.2011.06.013","article-title":"Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy rates","volume":"159","author":"Mart\u00ednez","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020043013460490200_ref27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.beem.2018.09.003","article-title":"The endometrium during and after ovarian hyperstimulation and the role of segmentation of infertility treatment","volume":"33","author":"Montoya-Botero","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020043013460490200_ref28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/dei302","article-title":"A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients","volume":"21","author":"Rombauts","year":"2006","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertil Steril"},{"key":"2020043013460490200_ref31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"key":"2020043013460490200_ref32","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jcem-33-6-917","article-title":"The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function","volume":"33","author":"Tsai","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013460490200_ref33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/humrep\/dew325","article-title":"Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome","volume":"32","author":"Wei","year":"2017","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/4\/826\/33149683\/dez299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/4\/826\/33149683\/dez299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T18:26:13Z","timestamp":1588271173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/4\/826\/5804205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dez299","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,3,12]]}}}